From other board, interesting take!! Aaron: DOJ

New Post Public Reply Private Reply Replies (3) Message Board
Figgs
1,126
From other board, interesting take!!

Aaron:
Quote:
DOJ INVESTIGATION:

As one poster points out nothing has been announced as a material event and the 10K goes through May only. We would have heard something by now unless it's a nothing burger.

Here is my two cents:

1) The 10K never says Cytodyn or it's board members are "UNDER" investigation. Only that they received subpoenas for information related to Leronlimab and conversations with the FDA and others

That's huge because of point two below.

2) The DOJ does not subpoena information from suspected criminals. "Hello, suspected criminals, would you be kind enough to hand over your incriminating evidence untampered so we can prosecute you?"

The DOJ notifies a suspected criminal last. Not first!!! Guess who gets contacted first in a DOJ investigation? Witnesses! (Look at the brain on Brad!)

3) Posters have pointed out the DOJ does not need subpoenas for public comments made. Well, they don't need to go to Cytodyn for private comments made to FDA, either!!! Guess who they can get those from? Right, the FDA!! "Hello, FDA, please cooperate in our Cytodyn investigation by handing over conversations with them, thanks"

But no, they didn't go to FDA, they asked for conversations directly from Cytodyn.

4) If Cytodyn had material information needed to prosecute Cytodyn, a warrant resulting in doors busted open and computers and all other correspondence seized to preserve evidence would have occurred.

That didn't happen so don't let the bashers make you think NP now has the DOJ on him.

5) That brings us to suspects. If the DOJ isn't looking into Cytodyn, then who? I found it pretty laughable the bashers immediately suspected Cytodyn when there is a whole laundry list of suspects.

THE UNUSUAL SUSPECTS:

1) Citron short attack:.

We all know what happened June of 2020. That was blatant stock manipulation. Possibly DOJ is finally getting around to it. One basher pointed out it's unlikely as that was fourteen months ago.

Uh, no. First, the 10K is up through May so that's 8-11 months after the attack.

Secondly, just because you first heard about it now doesn't mean DOJ hasn't been secretly investigating all this time. They wouldn't contact Cytodyn with subpoenas at the very beginning of the investigation.

And finally, DOJ is slow and this is probably a small fish to fry all things considered. Still the Citron attack was a multi-million dollar crime if prosecuted.

2) bogus lawsuit firms:

The mass advertising attack was destructive to the stock price. What would Cytodyn conversations have to do with fake lawsuits? Well, if you are going to prove they are fake, you need the actual conversations with FDA as well as investors that show it was the lawsuits themselves depressing the stock.

Why need a subpoena for something that would help Cytodyn? That's probably to cover Cytodyn in case private information is handed over to authorities. Cytodyn needs to show they were subpoena'd. They have enough lawsuits as it is.

3) Bruce Patterson:

Yes, this has to be considered.

Bruce actually caused a spike in stock price by mentioning there were discussions ongoing with OWS. Remember that?

Then BP refused to hand over assays which were needed for FDA submission and stock plummeted.

BP owns stock. Even if he didn't, he could have told people he knows what influential moves he was planning on doing.

We still don't know what BP/NP split was about but if NP suspected these types of shenanigans that would be a good reason to sever the relationship and also keep mum(as they are heavy charges to make without definitive proof)

BP is a respected physician but start connecting the dots is all I am saying!

4) FDA

At first it may sound far fetched but remember point two above. DOJ contacts the suspect last for info. They asked for conversations between Cytodyn and FDA from Cytodyn, not the FDA!

Has the FDA done anything recently that might trigger suspicion? Approving drugs that cause board members to resign in protest? Approving drugs with serious side effects that seem not to work for multi-million dollar conglomerates? Causing an investigation by the head of the FDA?

All of the above could have gotten a DOJ investigation for possible corruption, bribery, kickbacks and, yeah, now that's a pretty damn big fish to fry for the DOJ.

But what does that have to do with Cytodyn? IDK, has there been any FDA notice released that seemed unusual, that seemed mysteriously misleading as to Leronlimab efficacy and safety and endpoints met(while other similar drugs were approved)? A letter that was posted just days before a multi-million dollar deal was to be announced with the Philippines? And which probably scuttled that along with causing a drop in stock price?

Who at the FDA wrote that letter and why? We're there any bribes, kickbacks, corruption?

If it is the FDA under investigation, you go to Cytodyn for the conversations showing FDA was Gung Ho privately. Not the FDA!
2

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Machine Grabs Prime Dallas Property Amid Apartment Boom

Updated Category News Views 7

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

Continue Reading
Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 7

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 8

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 6

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 3

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 6

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 8

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading

Top 5 Most Recently Viewed Articles

New Eagle Partners with Bosch to Enhance Mobility Solutions

Updated Category News Views 144

New Eagle Partners with Bosch for Enhanced Mobility Solutions Bringing Bosch's Trusted Mobility Components to Market with New Eagle's Engineering Depth and Speed New Eagle™, a prominent leader in embedded control systems for intelligent vehicles and machines, is excited to announce its official role as a distributor for Bosch Mobility Aftermarket across North America....

Continue Reading
Adams Natural Resources Fund Announces Shareholder Distribution

Updated Category News Views 147

Adams Natural Resources Fund Declares Exciting Distribution On a recent announcement, Adams Natural Resources Fund, Inc. (NYSE: PEO) has revealed a distribution amounting to $0.52 per share that is set to be payable to its shareholders. This distribution is expected on the 28th of May, catering to those who will hold shares by the 28th of April. Investors have the...

Continue Reading
Dr. Gunther von Hagens: A Legacy of Human Anatomy

Updated Category News Views 8

A Groundbreaking Visionary in Anatomy Passes The world has lost a pioneer in anatomical science. Dr. Gunther von Hagens, inventor of the groundbreaking technique known as Plastination and creator of the BODY WORLDS exhibitions, passed away on July 24, 2026, at the age of 81. His innovative work fundamentally changed the way we view and understand human anatomy. Not quite...

Continue Reading
ExxonMobil And QatarEnergy's Golden Pass LNG Project Updates

Updated Category News Views 724

Golden Pass LNG Project Receives Extended Export Permit Chris Wright, the U.S. Secretary of Energy, has recently confirmed an extension for the export permit of the Golden Pass LNG project. This significant project represents a collaborative effort between QatarEnergy and ExxonMobil (XOM) and is currently under construction in Sabine Pass, Texas. Details of the Extension...

Continue Reading
Li Bang International Transitions to Class A Ordinary Shares

Updated Category News Views 175

Li Bang International's Stock Transition Explained Li Bang International Corporation Inc. has officially announced significant changes to its stock structure, marking an exciting evolution for the company and its stakeholders. Operating in the stainless steel commercial kitchen equipment sector, Li Bang is ready to make a notable impact. Introduction of Class A Ordinary...

Continue Reading